Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Fresenius Medical Care AG & Co. KGaA (FMCQF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
47.200.00 (0.00%)
At close: 03:47PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close47.20
Open50.81
BidN/A x N/A
AskN/A x N/A
Day's Range47.20 - 47.20
52 Week Range46.43 - 83.75
Volume1
Avg. Volume6,068
Market Cap14.607B
Beta (5Y Monthly)0.94
PE Ratio (TTM)14.94
EPS (TTM)3.16
Earnings DateN/A
Forward Dividend & Yield1.41 (2.99%)
Ex-Dividend DateMay 13, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for FMCQF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • FRESENIUS MEDICAL CARE AG & CO
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features the changing winds of solar energy, the wide moats in network security, our pondering Zendesk's recent acquisition, and Fresenius, Deliveroo, and New World Development.
    Rating
    Fair Value
    Economic Moat
    5 months agoMorningstar
View more
  • Reuters

    UPDATE 1-U.S. Supreme Court rules against DaVita over dialysis coverage

    The U.S. Supreme Court on Tuesday rejected dialysis provider DaVita Inc's claims that an Ohio hospital's employee health plan discriminates against patients with end-stage kidney disease by reimbursing them at low rates in hopes they would switch to Medicare. In a 7-2 decision https://fingfx.thomsonreuters.com/gfx/legaldocs/byvrjaqorve/06212022davita.pdf authored by conservative Justice Brett Kavanaugh, the court ruled that Marietta Memorial Hospital's employee health plan did not violate federal law by limiting benefits for outpatient dialysis because it did so without regard to whether patients had end-stage renal disease.

  • Zacks

    Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

    Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.

  • Business Wire

    Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce

    HONG KONG, May 12, 2022--Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care’ campaign that celebrates the diversity, unity and positive impact of its nurses and clinical teams across Asia Pacific, Europe, the Middle East and Africa, North America and Latin America.

Advertisement
Advertisement